Hyd-based firm gets DGCI nod to start clinical trials for its COVID-19 antidote VINCOV-19

The antidote was developed in collaboration with the University of Hyderabad and CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB)

By Newsmeter Network  Published on 27 April 2021 1:01 PM GMT